prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, FINAL DIAGNOSIS: PART 1: RIGHT SENTINEL LYMPH NODE #1, BIOPSY -. ONE LYMPH NODE NEGATIVE FOR TUMOR (0/1). PART 2: RIGHT BREAST, SEGMENTAL MASTECTOMY -. A. INFILTRATING DUCT CARCINOMA, 1.5 X 1.4 X 1.4 CM. B. NOTTINGHAM SCORE 9/9 (TUBULES 3, NUCLEAR 3, MITOSES 3). C. NO LYMPHOVASCULAR INVASION IDENTIFIED. D. DUCTAL CARCINOMA IN-SITU SOLID TYPE, NUCLEAR GRADE3, WITH COMEDO-TYPE NECROSIS. TISSUE. COMPRISING APPROXIMATELY 3% OF INVASIVE TUMOR AND PRESENT IN THE SURROUNDING BREAST. E. SURGICAL MARGINS NEGATIVE FOR INFILTRATING DUCT CARCINOMA AND DUCTAL CARCINOMA IN-. SITU. F. G. INFILTRATING DUCT CARCINOMA FOCALLY VERY CLOSELY APPROACHES SUPERIOR MARGIN (0.03 CM). UNREMARKABLE SKIN. H. TUMOR IS ESTROGEN RECEPTORS, PROGESTERONE RECEPTORS AND HER2/NEU NEGATIVE AS PER. CORE BIOPSY REPORT. I. THERMAL EFFECT. COMMENT: The tumor has pushing margins, is associated with prominent lymphocytic infiltrate and is cytokeratin 5 and 6,. and Her2/neu negative. which supports the diffarentiation. cytokeratin 14, cytokeratin 17, epidermal growth factor and vimentin positive and estrogen and progesterone receptor. CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST. LATERALITY: Right. PROCEDURE: Segmental. Not specified. SIZE OF TUMOR: Maximum dimension invasive component: 1.4 cm. MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): Other Type(s): basal-like type. NOTTINGHAM SCORE: Nuclear grade: 3. Tubule formation: 3. Mitotic activity score: 3. Total Nottingham score: 9. Nottingham grade (1, 2, 3): 3. ANGIOLYMPHATIC INVASION: DERMAL LYMPHATIC INVASION: CALCIFICATION: TUMOR TYPE, IN SITU: Solid, Comedo. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Distance of invasive tumor to closest margin: 0.3 mm. SURG MARGINS INVOLVED BY IN SITU COMPONENT: LYMPH NODES POSITIVE: 0. LYMPH NODES EXAMINED: 1. METHOD(S) OF LYMPH NODE EXAMINATION: H/E stain, Keratin stain. SENTINEL NODE METASTASIS: SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 0 mm. LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: NON-NEOPLASTIC BREAST TISSUE: FCD. T STAGE, PATHOLOGIC: N STAGE, PATHOLOGIC: pNO. pMX. M STAGE, PATHOLOGIC: ESTROGEN RECEPTORS: negative. PROGESTERONE RECEPTORS: negative. HER2/NEU: zero or 1+.

expanded version (tokens=1196) : 
 Histological classification: The breast pathology report shows that the patient has a subtype of Basal type cancer. The report also mentions the presence of Infiltrating Ductal Carcinoma and Ductal Carcinoma in-situ solid type with comedo-type necrosis.

Nuclear Grade: The Nuclear grade of the tumor is mentioned as 3.

Lymphovascular invasion: The report mentions that no lymphovascular invasion is identified.

Histological Grade: The Nottingham score is mentioned in the report which is 9/9 (Tubules 3, Nuclear 3, Mitoses 3), indicating a high histological grade of the tumor.

Necrosis: The report shows that the Ductal Carcinoma in-situ solid type has comedo-type necrosis.

Tumor infiltrating lymphocytes: The report states that the tumor is associated with a prominent lymphocytic infiltrate.

Calcification: The report mentions the presence of calcification.

Receptor status: The tumor is negative for Estrogen receptors, Progesterone receptors, and HER2/NEU as per the core biopsy report.

Ancillary testing results: The report also mentions the results of ancillary testing which shows positive for cytokeratin 14, cytokeratin 17, epidermal growth factor, and vimentin.

In summary, the patient has Basal type cancer with Infiltrating Ductal Carcinoma and Ductal Carcinoma in-s

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1392) : 
 The patient has Basal type cancer with Infiltrating Ductal Carcinoma and Ductal Carcinoma in-situ solid type with comedo-type necrosis. The Nuclear grade of the tumor is 3, and No lymphovascular invasion is identified. The Nottingham score is 9/9 (Tubules 3, Nuclear 3, Mitoses 3), indicating high-grade tumor. Tumor is negative for Estrogen receptors, Progesterone receptors, and HER2/NEU by core biopsy report. Ancillary testing showed positive for cytokeratin 14, cytokeratin 17, epidermal growth factor, and vimentin associated with a prominent lymphocytic infiltrate.

